Levetiracetam May be the First Choice for Managing Epilepsia Partialis Continua Related to Ischemic Stroke

Creative Commons License

YÖN M. İ., Ulusoy E. K., Bilen S., Yon M. E. E.

ERCIYES MEDICAL JOURNAL, vol.38, no.4, pp.157-158, 2016 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 38 Issue: 4
  • Publication Date: 2016
  • Doi Number: 10.5152/etd.2016.150054
  • Journal Name: ERCIYES MEDICAL JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.157-158
  • Gazi University Affiliated: Yes

Abstract

An 82-year-old, right-handed male patient was admitted to the emergency room because of continuous rhythmic clonic movements of the right forearm and hand. He was diagnosed with epilepsia partialis continua (EPC) and treated successfully with levetiracetam. In conclusion, we recommend levetiracetam as the first line treatment for EPC, which is mostly refractory to classical antiepileptic drugs.